1Discussion on the biosimilars' particularity and regulatory policyCHEN Hao1201-12042The impact of R&D outsourcing on innovation performance of Chinese pharmaceutical enterprises: incentives or inhibitionsSHU Yan, ZHANG Kai-yi1205-12103New PARP inhibitor talazoparibHUANG Lu, LU Yi, HONG Yi, LU Shan, XU Yong1211-12154Brexanolone: a new drug for adult women with postpartum depressionZHAO Xiao-juan, ZHOU Li-ming, WANG Yong-jing, ZHAO Yong-hong, HE Wen-juan1216-12215Introduction and consideration of communication during the clinical trial of new drugs in the U.S.WANG Jing-can, WEN Bao-shu, CHEN Cheng-li1222-12266Considerations on new drug application for anti-chronic lymphocytic leukemia drug from single arm trialZOU Li-min, TANG Ling, QI Yue-li, DU Yu, YANG Zhi-min1227-12307Impurity control strategy of β-1actam antibiotics polymer:the formation and developmentHU Chang-qin1231-12448Considerations of the analytical method selection for biological samples of peptide drugZHAI Jian-ping, DONG Li-hou, XIANG Shen-si, LI Li, GE Zhi-qiang1245-12509Stability study of haemophilus influenzae type b conjugate vaccineCHEN Zhong-wei, LIU Xiao-lei, WANG Zhen-ye, LIU Feng, CHU Zi-qing, MU Shan-shan, SUN Shu-xue1251-125610Advances in structural modification and structure-activity relationship of berberineWU Long-long, FANG Fang1257-126411Treatment of renal cell carcinoma by cabozantinib:efficacy, safety evaluation and managementCHEN Na, ZHAN Shi-peng, LIU Fang1265-126912Construction of indicators set of core competencies for research nurse in clinical trialsLI Yan, LI Jian, LU Hong1270-127513Screening of a novel mouse monoclonal antibody against Frizzled7 and its humanization designXIE Wei, PAN Wei, CHAI Bin-shu, CAO Yu, WANG Yi-yun, XU Yan-jie, WANG Jin1276-128414Preparation and in vitro antitumor evaluation of pH-sensitive doxorubicin prodrug nanoparticlesYOU Chong-zhao, MAO Jing, XU Jia-min, QIU Li-peng, CHEN Jing-hua1285-129115Study on preparation process of dexlansoprazole for injectionZHANG Yu-xia, TAN Ding-yuan, ZHAO Yue-xin, ZHAO Min, WANG Miao, ZHAO Chun-jie1292-129616Determination of related substances of carteolol hydrochloride eye drops by HPLCLI Zheng-yan, LIU Yu, LIU Wei1297-130017The process and analysis on complaint feedback of antibacterial order review based on evidence-based medicineYING Ying-qiu, LI Xiao-xiao, YANG Li, KONG Jie, XU Xue-dong, ZHAI Suo-di1301-130418Systematic evaluation and Meta-analysis of the efficacy and safety of sulodexide combined with simvastatin in the treatment of lower-extremity arterial diseaseDU Yu-qing, LI Tian-li, CHEN Run-ming, DONG Xue-yu, AN Qi, LI You-shan, LIU Ya-li1305-131219Safety and efficacy of azilsartan medoxomil in the treatment of primary hypertension: a Meta-analysisCAO Wang, LIU Yong-jun1313-1320 